Cellenkos Inc. and King Faisal Specialist Hospital Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases
- Written by PR Newswire
![]() |
- KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host Disease
- Cellenkos to Support Local Cell and Gene Therapy Manufacturing at KFSHRC
RIYADH, Saudi Arabia and HOUSTON, May 22, 2025 /PRNewswire/ -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Cellenkos® Inc., a Texas based clinical stage biotech...















